Pulmonx Corporation (NASDAQ: LUNG) reported Q2 EPS of ($0.39), $0.03 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $20.8 million versus the consensus estimate of $20.15 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.